Studies have demonstrated that EVs functionalized with integrin-targeting peptides or transferrin receptor ligands significantly enhance their uptake by GBM cells, facilitating the intracellular delivery of chemotherapeutic agents and radiosensitizers [28]. The gene discussed is TFRC; the disease is glioblastoma.